# A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction

> **NCT05690711** · PHASE2 · COMPLETED · sponsor: **Beijing Suncadia Pharmaceuticals Co., Ltd** · enrollment: 40 (actual)

## Conditions studied

- Brain Swelling, Large Hemispheric Infarction

## Interventions

- **DRUG:** HRS8179
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05690711
- **Lead sponsor:** Beijing Suncadia Pharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-07
- **Primary completion:** 2023-12-05
- **Final completion:** 2024-02-27
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05690711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05690711, "A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05690711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*